Statement: Both cohorts of the primary trial are administered the same drugs in different doses .
Primary_evidence: INTERVENTION 1:    Treatment Period 1   Participants received AZD9496 - Variant A (100 mg). INTERVENTION 2:    Treatment Period 2   Participants received AZD9496 - Reference (100 mg).